Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ROIC - WACC | (485.3%) | (425.7%) | (563.4%) | (1,968.0%) | 3,800.9% | (264.7%) | (14.6%) | (1,178.2%) | (3.5%) | (34.9%) | (11.2%) | 29.1% | 28.1% | (37.7%) | 8.1% | 32.9% | (30.2%) | 61.8% | 18.2% | 16.1% |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Microsoft Corp's last 12-month ROIC - WACC is (24.0%), based on the financial report for Sep 30, 2024 (Q3 2024). The average annual ROIC - WACC for Incyte Corporation have been 24.4% over the past three years, and 14.6% over the past five years.
As of today, Incyte Corporation's ROIC - WACC is (24.0%), which is higher than industry median of (127.8%). It indicates that Incyte Corporation's ROIC - WACC is Good.